High‐dose intravenous immunoglobulin therapy for scleromyxoedema: a prospective open‐label clinical trial using an objective score of clinical evaluation system

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles